ctrl K

Advertisement

Bolt Biotherapeutics Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD

0.35

-0.02 (-5.46%)

Apr 29, 2025, 10:44 AM - Market open

Bolt Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	7.69M	7.88M	5.73M	1.26M	231K	215K	n/a
Cost of Revenue	n/a	1.88M	4.89M	3.67M	40.36M	26M	302K
Gross Profit	7.69M	5.99M	838K	-2.41M	-40.13M	-25.79M	-302K
Operating Income	-73.05M	-76.2M	-90.32M	-92.79M	-49.18M	-30.97M	-11.63M
Interest Income	5.25M	7M	2.22M	281K	199K	524K	193K
Pretax Income	-63.12M	-69.2M	-88.1M	-98.59M	-60.73M	-30.49M	-11.59M
Net Income	-63.12M	-69.2M	-85.88M	-104.39M	-72.27M	-30M	-11.59M
Selling & General & Admin	18.46M	22.53M	22.93M	18.39M	9.06M	5.18M	2.21M
Research & Development	57.47M	61.54M	73.12M	75.66M	40.36M	26M	9.42M
Other Expenses	4.81M	n/a	n/a	-6.08M	-11.74M	-42K	-153K
Operating Expenses	80.74M	84.07M	96.05M	94.05M	49.41M	31.18M	11.63M
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	80.74M	84.07M	96.05M	94.05M	49.41M	31.18M	11.63M
Income Tax Expense	n/a	n/a	-2.22M	5.8M	11.55M	-482K	40K
Shares Outstanding (Basic)	38.18M	37.81M	37.36M	37.4M	36.25M	35.1M	9.42M
Shares Outstanding (Diluted)	38.18M	37.81M	37.36M	37.4M	36.25M	35.1M	9.42M
EPS (Basic)	-1.65	-1.83	-2.3	-2.79	-1.99	-0.85	-1.23
EPS (Diluted)	-1.65	-1.83	-2.3	-2.79	-1.99	-0.85	-1.23
EBITDA	-66.45M	-74.34M	-88.66M	-91.59M	-48.57M	-30.63M	-11.33M
EBIT	-68.24M	-76.2M	-90.32M	-92.79M	-49.18M	-30.97M	-11.59M
Depreciation & Amortization	1.78M	1.85M	4.89M	3.67M	2.5M	1.33M	302K